VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Friday, January 2, 2026
Stock Comparison
Intercontinental Exchange, Inc. vs Novartis AG
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Intercontinental Exchange, Inc.
ICE · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Intercontinental Exchange, Inc.'s moat claims, evidence, and risks.
View ICE analysisNovartis AG
NOVN · SIX Swiss Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novartis AG's moat claims, evidence, and risks.
View NOVN analysisComparison highlights
- Moat score gap: Intercontinental Exchange, Inc. leads (87 / 100 vs 65 / 100 for Novartis AG).
- Segment focus: Intercontinental Exchange, Inc. has 3 segments (53.4% in Exchanges); Novartis AG has 5 segments (29.3% in Oncology).
- Moat breadth: Intercontinental Exchange, Inc. has 10 moat types across 4 domains; Novartis AG has 4 across 3.
Primary market context
Intercontinental Exchange, Inc.
Exchanges
Derivatives, cash equities, and listings exchanges plus central clearing (CCP) services
Global
Market participants (banks, broker-dealers, asset managers, proprietary traders) and issuers
Exchange operator + clearing house (CCP)
53.4%
Novartis AG
Oncology
Oncology and hematology branded medicines (including targeted therapies and radioligand therapy)
Global
Oncologists and hospitals; reimbursed by payers; hospital and specialty pharmacy channels
Originator developer, manufacturer, and marketer of oncology therapies
29.3%
Side-by-side metrics
Moat coverage
Shared moat types
Intercontinental Exchange, Inc. strengths
Novartis AG strengths
Segment mix
Intercontinental Exchange, Inc. segments
Full profile >Exchanges
Oligopoly
Fixed Income and Data Services
Oligopoly
Mortgage Technology
Oligopoly
Novartis AG segments
Full profile >Cardiovascular, Renal and Metabolic
Oligopoly
Immunology
Oligopoly
Neuroscience
Oligopoly
Oncology
Oligopoly
Established Brands
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.